Section 2070.10  Definitions

a)         "Act" as used in this part means the "Illinois Controlled Substances Act," effective August 16, 1971, as amended.

b)         The definitions contained in Section 102 of the Act are applicable herein, unless the context otherwise requires.

Section 2070.20  Designated Products

The Department finds that the following Controlled Substances listed in Schedule II (Subpart C) require use of an official prescription blank for dispensation:  any narcotic drug, amphetamine, glutethimide, phenmetrazine, methamphetamine, pentazocine, or cannabis product.

(Source:  Amended at 11 Ill. Reg. 5192, effective March 17, 1987)

Section 2070.30  Names Given to Listed Drugs

The controlled substances listed or to be listed in the schedules contained in this part are included by whatever official, common, usual, chemical or trade name designated.

Section 2070.40  Excluded Substances

The non-narcotic substances excluded from all schedules of the Federal Controlled Substances Act (21 U.S.C. 801 et seq.) as of January 1, 1974, pursuant to Section 1308.22 of the Code of Federal Regulations (21 CFR 1308.22), are excluded from all schedules of the Act.

Section 2070.50  Excepted Compounds

The compounds in the form excepted from application of certain specified sections of the Federal Controlled Substances Act (21 U.S.C. 801 et seq.), the Federal Controlled Substances Import and Export Act (21 U.S.C. 951 et seq.), and the Code of Federal Regulations, pursuant to Section 1308.32 of the Code of Federal Regulations(21 C.F.R. 1308.32) are excepted from the application of Sections 312 and 313 of this Act.

Section 2070.100  Schedule I − Criteria

The Department finds that the substances enumerated in Schedule I following meet the criteria established in Section 203 of the Act.

Section 2070.110  Schedule I − Enumeration

The controlled substances listed in these Sections 2070.110 to 2070.810 are included in Schedule I.

Section 2070.115  Opiates

Unless specifically excepted or unless listed in another schedule, any of the following opiates listed in Sections 2070.120 to 2070.395, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

Section 2070.117  AB-CHMINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

AB-CHMINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole‑3‑carboxamide

(Source:  Added by peremptory rulemaking at 39 Ill. Reg. 3171, effective February 13, 2015)

Section 2070.118  AB-PINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

AB-PINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1Hindazole-3-carboxamide

(Source:  Added by peremptory rulemaking at 39 Ill. Reg. 3171, effective February 13, 2015)

Section 2070.120  Acetylmethadol

Acetylmethadol

Section 2070.122  Acetyl-alpha-methylfentanyl

Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-

phenylacetamide

(Source:  Added at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.124  Alfentanil (Renumbered)

(Source:  Former Section 2070.124 renumbered to Section 2070.1186 at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.125  Allylprodine

Allylprodine

Section 2070.130  Alphacetylmethadol

Alphacetylmethadol, except levo-alphacetylmethadol (also known as:  levo-alpha-

acetylmethadol, levomethadyl acetate, or LAAM)

(Source:  Amended at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.135  Alphameprodine

Alphameprodine

Section 2070.140  Alphamethadol

Alphamethadol

Section 2070.145  Alpha-methylfentanyl

Alpha-methylfentanyl (N-(l-alpha-methyl-beta-phenyl)ethyl-4-piperidyl)

propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)

piperidine)

(Source:  Amended at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.146  Alpha-methylthiofentanyl

Alpha-methylthiofentanyl (N-[1-menthyl-2-(2-thienyl) ethyl-4-piperideinyl]-N-

phenylpropanamide)

(Source:  Added at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.147  1-methyl-4-phenyl-4-propionoxypiperdine (MPPP)

1-methyl-4-phenyl-4-propionoxypiperdine (MPPP)

(Source:  Added at 10 Ill. Reg. 11222, effective June 16, 1986)

Section 2070.148  PEPAP 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine

PEPAP 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine)

(Source:  Amended at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.150  Benzethidine

Benzethidine

Section 2070.155  Betacetylmethadol

Betacetylmethadol

Section 2070.157  Beta-hydroxyfentanyl

Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-

phenylpropanamide)

(Source:  Added at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.160  Betameprodine

Betameprodine

Section 2070.165  Betamethadol

Betamethadol

Section 2070.170  Betaprodine

Betaprodine

Section 2070.175  Clonitazene

Clonitazene

Section 2070.180  Dextromoramide

Dextromoramide

Section 2070.185  Diampromide

Diampromide

Section 2070.190  Diethylthiambutene

Diethylthiambutene

Section 2070.195  Difenoxin

Difenoxin

Section 2070.200  Dimenoxadol

Dimenoxadol

Section 2070.205  Dimepheptanol

Dimepheptanol

Section 2070.210  Dimethylthiambutene

Dimethylthiambutene

Section 2070.220  Dioxaphetylbutyrate

Dioxaphetylbutyrate

Section 2070.230  Dipipanone

Dipipanone

Section 2070.235  Ethylmethylthiambutene

Ethylmethylthiambutene

Section 2070.240  Etonitazene

Etonitazene

Section 2070.245  Etoxeridine

Etoxeridine

Section 2070.247  3-Methylfentanyl (Renumbered)

(Source:  Former Section 2070.247 renumbered to Section 2070.272 at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.250  Furethidine

Furethidine

Section 2070.255  Hydroxpethidine

Hydroxpethidine

Section 2070.260  Ketobemidone

Ketobemidone

Section 2070.265  Levomoramide

Levomoramide

Section 2070.270  Levophenacylmorphan

Levophenacylmorphan

Section 2070.271  U-47700

U-47700 3,4-dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-methylbenzamide

(Source:  Added at 41 Ill. Reg. 1801, effective January 25, 2017)

Section 2070.272  3-Methylfentanyl

3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)

(Source:  Section 2070.272 renumbered from Section 2070.247 and amended at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.273  3-Methylthiofentanyl

3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenyl-

propanamide)

(Source:  Added at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.275  Morpheridine

Morpheridine

Section 2070.280  Noracymethadol

Noracymethadol

Section 2070.285  Norlevorphanol

Norlevorphanol

Section 2070.290  Normethadone

Normethadone

Section 2070.295  Norpipanone

Norpipanone

Section 2070.297  Para-fluorofentanyl

Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide)

(Source:  Added at 20 Ill. Reg 3081 effective February 2, 1996)

Section 2070.300  Phenadoxone

Phenadoxone

Section 2070.310  Phenampromide

Phenampromide

Section 2070.320  Phenomorphan

Phenomorphan

Section 2070.330  Phenoperidine

Phenoperidine

Section 2070.340  Piritramide

Piritramide

Section 2070.350  Proheptazine

Proheptazine

Section 2070.360  Properidine

Properidine

Section 2070.370  Propiram

Propiram

Section 2070.380  Racemoramide

Racemoramide

Section 2070.385  Sufentanil (Renumbered)

(Source:  Section 2070.385 renumbered to Section 2070.1265 at 8 Ill. Reg. 21212, effective October 19, 1984)

Section 2070.388  Thiofentanyl

Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.389  THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl) methanone

THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone

(Source:  Added by peremptory rulemaking at 39 Ill. Reg. 3171, effective February 13, 2015)

Section 2070.390  Tilidine

Tilidine

(Source:  Amended at 5 Ill. Reg. 5156, effective April 29, 1984)

Section 2070.395  Trimeperidine

Trimeperidine

Section 2070.397  Beta-hydroxy-3-methylfentanyl

Beta-hydroxy-3-methylfentanyl (other name:  N-[1-(2-hydroxy-2-phenethyl)-3-

methyl-4-piperidinyl]-N-phenylpropanamide)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.400  Opium Derivates

Unless specifically excepted or unless listed in another schedule, any of the opium derivatives, listed in the following Sections 2070.405 to 2070.520, its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation listed.

Section 2070.405  Acetorphine

Acetorphine

Section 2070.410  Acetyldihydrocodeine

Acetyldihydrocodeine

Section 2070.412  Alpha-pyrrolidinobutiophenone ("a-PBP")

Alpha-pyrrolidinobutiophenone ("a-PBP")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.414  Alpha-pyrrolidinopentiophenone ("a-PVP")

Alpha-pyrrolidinopentiophenone ("a-PVP")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.415  Benzylmorphine

Benzylmorphine

Section 2070.420  Codeine methylbromide

Codeine methylbromide

Section 2070.425  Codeine-N-Oxide

Codeine-N-Oxide

Section 2070.430  Cyprenorphine

Cyprenorphine

Section 2070.435  Desomorphine

Desomorphine

Section 2070.440  Diacetyldihydromorphine (Dihydroheroin)

Diacetyldihydromorphine (Dihydroheroin)

Section 2070.445  Dihydromorphine

Dihydromorphine

Section 2070.450  Drotebanol

Drotebanol

Section 2070.455  Etorphine (except hydrochloride salt)

Etorphine (except hydrochloride salt)

Section 2070.460  Heroin

Heroin

Section 2070.465  Hydromorphinol

Hydromorphinol

Section 2070.470  Methyldesorphine

Methyldesorphine

Section 2070.475  Methyldihydromorphine

Methyldihydromorphine

Section 2070.480  Morphine methylbromide

Morphine methylbromide

Section 2070.485  Morphine methylsulfonate

Morphine methylsulfonate

Section 2070.490  Morphine-N-Oxide

Morphine-N-Oxide

Section 2070.495  Myrophine

Myrophine

Section 2070.500  Nicocodeine

Nicocodeine

Section 2070.505  Nicomorphine

Nicomorphine

Section 2070.510  Normorphine

Normorphine

Section 2070.515  Pholcodine

Pholcodine

Section 2070.520  Thebacon

Thebacon.

Section 2070.530  1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one ("butylone")

1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one ("butylone")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.540  1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one ("pentylone")

1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (“pentylone”)

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.545 1-(naphthalene-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one ("naphyrone")

1-(naphthalene-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one ("naphyrone")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.600  Hallucinogenic Substances

Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the hallucinogenic substances listed in the following Sections 2070.605 to 2070.715, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.  (For the purpose of Sections 2070.600 to 2070.715 only, the term "isomer" includes the optical, position and geometric isomers listed in the following Sections 2070.605 to 2070.715).

Section 2070.602  2-(methylamino)-1-phenylpentan-1-one ("pentedrone")

2-(methylamino)-1-phenylpentan-1-one ("pentedrone")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.604  3-fluoro-N-methylcathinone ("3-FMC")

3-fluoro-N-methylcathinone ("3-FMC")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.605  3, 4 Methylenedioxyamphetamine

3, 4-methylenedioxyamphetamine (alphamethyl, 3, 4-methylenedioxy-phenethylamine, methylenedioxyamphetamine, MDA)

Section 2070.606  Alpha-ethyltryptamine

Alpha-ethyltryptamine (some trade or other names:  etryptamine; MOASE, alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl)indole; a-ET, and AET)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.607  3,4 Methylenedioxymethamphetamine (MDMA)

3,4 Methylenedioxymethamphetamine

(Source:  Added at 10 Ill. Reg. 18159, effective October 8, 1986)

Section 2070.608  3,4-methylenedioxy-N-ethylamphetamine

3,4-methylenedioxy-N-ethylamphetamine (also known as:  N-ethyl-alpha-methyl-

3,4(methylenedioxy) Phenethylamine, N-ethyl, MDA, MDE, and MDEA)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.610  3-methoxy-4, 5-methylenedioxyamphetamine, MMDA

3-methoxy-4, 5-methylenedioxyamphetamine, MMDA

Section 2070.615  3, 4, 5-trimethoxyamphetamine (TMA)

3, 4, 5-trimethoxyamphetamine (TMA)

Section 2070.616  4-fluoro-N-methylcathinone ("4-FMC")

4-fluoro-N-methylcathinone ("4-FMC")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.617  4-methyl-N-ethylcathinone ("4-MEC")

4-methyl-N-ethylcathinone ("4-MEC")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.618  4-methylapha-pyrrolidinopropiophenone ("4-MePPP")

4-methylapha-pyrrolidinopropiophenone ("4-MePPP")

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

Section 2070.619  N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl)

N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters and ethers.

(Source:  Added by peremptory rulemaking at 41 Ill. Reg. 7014, effective June 1, 2017)

Section 2070.620  5-hydroxydimethyltryptamine (Bufotenine)

5-hydroxydimethyltryptamine (Bufotenine)

Section 2070.625  Diethyltryptamine (DET)

Diethyltryptamine (DET)

Section 2070.630  Dimethyltryptamine (DMT)

Dimethyltryptamine (DMT)

Section 2070.635  4-methyl, 2, 5-dimethoxyamphetamine (DOM, STP)

4-methyl, 2, 5-dimethoxyamphetamine (DOM, STP)

Section 2070.640  Ibogaine

Ibogaine (some trade and other names:  7-ethyl-6,6,beta,7,8,9,10,12,12-octahydro-

2-methoxy-6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole; Tabernatnthe

iboga)

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.645  Lysergic acid diethylamide

Lysergic acid diethylamide

Section 2070.650  3, 4, 5-trimethoxyphenethylamine (Mescaline)

3, 4, 5-trimethoxyphenethylamine (Mescaline)

Section 2070.655  Peyote

Peyote (meaning all parts of the plant presently classified botanically as Lophophora williemaii Lemaire, whether growing or not, the seeds thereof, any extract from any part of that plant, and every compound, manufacture, salts, derivative, mixture, or preparation of that plant, its seeds or extracts)

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.660  N-ethyl-3-piperidyl benzilate (JB 318)

N-ethyl-3-piperidyl benzilate (JB 318)

Section 2070.665  N-methyl-3-piperidyl benzilate

N-methyl-3-piperidyl benzilate

Section 2070.667  N-hydroxy-3,4-methylenedioxyamphetamine

N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-

3,4(methylenedioxy)phenethylamine and N-hydroxy MDA)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.670  Parahexyl

Parahexyl; some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6 H-dibenzo (b,d) pyran; synhexyl.

Section 2070.675  Psilocybin

Psilocybin

Section 2070.680  Psilocyn

Psilocyn

Section 2070.685  Alpha-methyltryptamine (AMT)

Alpha-methyltryptamine (AMT)

Section 2070.690  2,5-dimethoxyamphetamine

2,5-dimethoxyamphetamine (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA)

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.695  4-bromo-2,5-dimethoxyamphetamine

4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA)

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.700  4-methoxyamphetamine (4-methoxy-alpha-methylphenethylamine;

paramethoxyamphetamine, PMA)

4-methoxyamphetamine (4-methoxy-alpha-methylphenethylamine;

paramethoxyamphetamine, PMA)

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.705  Thiophene analog of phencyclidine (TPCP)

Thiophene analog of phencyclidine (TPCP)

Section 2070.710  Ethylamine analog of phencyclidine

Ethylamine analog of phencyclidine.  Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE

(Source:  Added at 3 Ill. Reg. 8, p. 112, effective February 23, 1979)

Section 2070.715  Pyrrolidine analog of phencyclidine

Pyrrolidine analog of phencyclidine.  Some trade or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy, PHP.

(Source:  Added at 3 Ill. Reg. 8, p. 112, effective February 23, 1979)

Section 2070.720  5-methoxy-3,4-methylenedioxy-amphetamine

5-methoxy-3,4-methylenedioxy-amphetamine

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.725  2,5-dimethoxy-4-ethylamphetamine

2,5-dimethoxy-4-ethylamphetamine (another name:  DOET)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.730  1-[1-(2-thienyl)cyclohexy1] pyrrolidine

1-[1-(2-thienyl)cyclohexyl] pyrrolidine (another name:  TCPy)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.735  3,4-methylenedioxy-amphetamine

3,4-methylenedioxy amphetamine

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.740  Thiophene analog of phencyclidine

Thiophene analog of phencyclidine (some trade or other names:  1-[1-(2-

thienyl)-cyclohexyl]-piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.745  Bufotenine

Bufotenine (some trade or other names:  3-(Beta-Dimethylaminoethyl)

-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; 5-hydroxy-N,N-

dimethyltryptamine; N,N-dimethylserotonin; mappine

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.750  Depressants

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.755 to 2070.760 having a depressant effect on the central nervous system including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

Section 2070.755  Mecloqualone

Mecloqualone

Section 2070.760  Methaqualone

Methaqualone

(Source:  Renumbered from Section 2070.1405 at 8 Ill. Reg. 16760, effective September 14, 1984)

Section 2070.800  Stimulants

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.805 and 2070.810 having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers.

Section 2070.805  Fenethylline

Fenethylline

Section 2070.810  N-ethylamphetamine

N-ethylamphetamine

Section 2070.815  Aminorex

Aminorex (some other names:  2-amino-5-phenyl-2-oxazoline; aminoxaphen; 4-5-dihydro-5-phenyl-2-oxazolamine) and its salts, optical isomers, and salts of optical isomers

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.820  Methcathinone

Methcathinone (some other names:  2-methylamino-1-phenylpropan-1-one;

Ephedrone; 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; N-methylcathinone; methycathinone; Monomethylpropion; UR 1431) and its salts, optical isomers, and salts of optical isomers.

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.825  Chathinone

Chathinone (some trade or other names:  2-aminopropiophenone; alpha-

aminopropiophenone; 2-amino-1-phenyl-propane; norephedrone)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.830  N,N-dimethylamphetamine

N,N-dimethylamphetamine (also known as:  N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.835  (+ or -) cis-4-methylaminorex

(+ or -) cis-4-methylaminorex ((+ or -) cis-4,5-dihydro-4-methyl-4-5-

phenyl-2-oxazolamine)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.619  N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl)

N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters and ethers.

(Source:  Added by peremptory rulemaking at 41 Ill. Reg. 7014, effective June 1, 2017)

Section 2070.900  Schedule II − Criteria

The Department finds that the substances enumerated in Schedule II following meet the criteria established in Section 205 of the Act.

Section 2070.910  Schedule II − Enumeration

The controlled substances listed in these Sections 2070.915 to 2070.1510 are included in Schedule II.

Section 2070.915  Narcotics

Unless specifically excepted or unless listed in another schedule, any of the substances listed in Sections 2070.920 to 2070.1130 whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis.

Section 2070.920  Opium and Opiates

Opium and opiates, and any salt, compound, derivative or preparation of opium or opiate, excluding apomorphine, dextrorphan, levopropoxyphene, nalbuphine, naloxone, and naltrexone, and their respective salts, but including those enumerated in Sections 2070.925 to 2070.998.

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.925  Raw Opium

Raw opium

Section 2070.930  Opium Extracts

Opium extracts

Section 2070.935  Opium Fluid Extracts

Opium fluid extracts

Section 2070.940  Powdered Opium

Powdered opium

Section 2070.945  Granulated Opium

Granulated opium

Section 2070.950  Tincture of Opium

Tincture of opium

Section 2070.955  Codeine

Codeine

Section 2070.960  Ethylmorphine

Ethylmorphine

Section 2070.965  Etorphine Hydrochloride

Etorphine Hydrochloride

Section 2070.970  Hydrocodone

Hydrocodone

Section 2070.975  Hydromorphone

Hydromorphone

Section 2070.980  Metopon

Metopon

Section 2070.985  Morphine

Morphine

Section 2070.990  Oxycodone

Oxycodone

Section 2070.995  Oxymorphone

Oxymorphone

Section 2070.998  Thebaine

Thebaine

Section 2070.999  Thebaine-derived butorphanol

Thebaine-derived butorphanol

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1100  Equivalencies

Any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in Section 2070.920, but not including the isoquinoline alkaloids of opium.

Section 2070.1110  Opium poppy and poppy straw

Opium poppy and poppy straw

Section 2070.1120  Cocaine

Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves, which extractions do not contain cocaine or ecgonine (for the purpose of this paragraph, the term "isomer" includes optical, positional and geometric isomers).

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1130  Concentrate of Poppy Straw

Concentrate of poppy straw (the crude extract of poppy  straw in either liquid, solid or powder form which contains the phenanthrine alkaloids of the opium poppy).

Section 2070.1150  Opiates

Unless specifically excepted or unless listed in another schedule any of the opiates listed in Sections 2070.1155 to 2070.1265, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation, dextrorphan excepted.

(Source:  Amended at 8 Ill. Reg. 21212, effective October 19, 1984)

Section 2070.1155  Alphaprodine

Alphaprodine

Section 2070.1160  Anileridine

Anileridine

Section 2070.1165  Bezitramide

Bezitramide

Section 2070.1170  Bulk Dextropropoxyphene

Bulk Dextropropoxyphene (Non-dosage forms)

Section 2070.1175  Dihydrocodeine

Dihydrocodeine

Section 2070.1180  Diphenoxylate

Diphenoxylate

Section 2070.1185  Fentanyl

Fentanyl

Section 2070.1186  Alfentanil

Alfentanil

(Source:  Renumbered from Section 2070.124 at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1187  Carfentanil

Carfentanil

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1190  Isomethadone

Isomethadone

Section 2070.1193  Levo-alphacetylmethadol

Levo-alphacetylmethadol (some other names:  levo-alpha-acetylmethadol, levomethadyl acetate, LAAM)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1195  Levomethorphan

Levomethorphan

Section 2070.1200  Levorphanol

Levorphanol (Levorphan)

Section 2070.1205  Metazocine

Metazocine

Section 2070.1210  Methadone

Methadone

Section 2070.1215  Methadone--Intermediate

Methadone--Intermediate, 4-cyano-2 dimethylamino-4,4-diphenyl-1-butane

Section 2070.1220  Moramide--Intermediate

Moramide--Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane--carboxylic acid

Section 2070.1225  Meperidine

Pethidine (meperidine)

Section 2070.1230  Pethidine-Intermediate-A

Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

Section 2070.1235  Pethidine-Intermediate-B

Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

Section 2070.1240  Pethidine-Intermediate-C

Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

Section 2070.1245  Phenazocine

Phenazocine

Section 2070.1250  Piminodine

Piminodine

Section 2070.1255  Racemethorphan

Racemethorphan

Section 2070.1260  Racemorphan

Racemorphan

Section 2070.1265  Sufentanil

Sufentanil

(Source:  Section 2070.1265 renumbered from Section 2070.385 at 8 Ill. Reg. 21212, effective October 19, 1984)

Section 2070.1300  Stimulants

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1310 to 2070.1370 having a stimulant effect on the central nervous system.

Section 2070.1310  Amphetamine

Amphetamine, its salts, optical isomers and salts of its optical isomers.

Section 2070.1320  Methamphetamine

Methamphetamine, its salts, isomers, and salts of its isomers.

Section 2070.1330  Methylphenidate

Methylphenidate

(Source:  Renumbered from Section 2070.1750 at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1370  Phenmetrazine

Phenmetrazine and its salts.

Section 2070.1400  Depressants

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1405 to 2070.1435 having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

Section 2070.1405  Methaqualone (Renumbered)

(Source:  Renumbered to Section 2070.760 at 8 Ill. Reg. 16760, effective September 14, 1984)

Section 2070.1410  Amobarbital

Amobarbital

Section 2070.1420  Secobarbital

Secobarbital

Section 2070.1425  Pentobarbital

Pentobarbital

Section 2070.1430  Phencyclidine

Phencyclidine

Section 2070.1435  Pentazocine

Pentazocine

Section 2070.1438  Gluthethimide

Gluthethimide

(Source:  Renumbered from 2070.1835 at 8 Ill. Reg. 13138, effective July 27, 1984)

Section 2070.1500  Immediate Precursors

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1505 to 2070.1510.

Section 2070.1505  Amphetamine and Methamphetamine

Immediate precursor to amphetamine and methamphetamine:

            Phenylacetone.  Some trade or other names:  phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.

Section 2070.1510  Phencyclidine

Immediate precursors to phencyclidine.

a)         1-phenylcyclohexylamine

b)         1-piperidinocyclohexanecarbonitrile (PCC).

Section 2070.1520  Nabilone

Nabilone

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1550  Dronabinol (oral solution)

Dronabinol (oral solution) and other names:  (6aR, 10aR)-6a,7,8,10a-tetrahydro-6,6,9- trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-o1.

(Source:  Amended at 45 Ill. Reg. 13018, effective October 4, 2021)

Section 2070.1600  Schedule III − Criteria

The Department finds that the substances enumerated in Schedule III following meet the criteria established in Section 207 of the Act.

Section 2070.1605  Schedule III − Enumeration

The controlled substances listed in these Sections 2070.1615 to 2070.2000 are included in Schedule III.

Section 2070.1610  Stimulants

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1615 to 2070.1640 having s stimulant effect on the central nervous system, including its salts, isomers, (whether optical position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

Section 2070.1615  Excepted Compounds

Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under  21 CFR 308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances.

Section 2070.1620  Benzphetamine

Benzphetamine

Section 2070.1625  Chlorphentermine

Chlorphentermine

Section 2070.1630  Clortermine

Clortermine

Section 2070.1635  Mazindol (Renumbered)

Mazindol

(Source:  Renumbered to Section 2070.2540 at 6 Ill. Reg. 7200, effective June 7, 1982)

Section 2070.1640  Phendimetrazine

Phendimetrazine

Section 2070.1700   Other Stimulants

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the substances listed in Section 2070.1750 having a potential for abuse associated with a stimulant effect on the central nervous system:

Section 2070.1750  Methylphenidate (Renumbered)

(Source:  Former Section 2070.1750 renumbered to Section 2070.1330 at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1800  Depressants

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1805 to 2070.1875 having a potential for abuse associated with a depressant effect on the central nervous system.

Section 2070.1805  Barbiturates

Any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or any salt of any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

Section 2070.1810  Barbiturates − Suppository Dosage Form

Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or any salt of any of these drugs and approved by the Federal Food and Drug Administration for marketing only as a suppository.

Section 2070.1825  Derivatives of Barbituric Acid

Any substance which contains any quantity of a derivative of barbituric acid, or any salt thereof.

Section 2070.1830  Chlorhexadol

Chlorhexadol

Section 2070.1835  Glutethimide

Glutethimide

(Source:  Renumbered to 2070.1438 at 8 Ill. Reg. 13135, effective July 27, 1984)

Section 2070.1840  Methyprylon

Methyprylon

Section 2070.1845  Sulfondiethylmethane

Sulfondiethylmethane

Section 2070.1850  Sulfonethylmethane

Sulfonethylmethane

Section 2070.1855  Sulfonmethane

Sulfonmethane

Section 2070.1860  Lysergic Acid

Lysergic acid

Section 2070.1865  Lysergic Acid Amide

Lysergic acid amide

Section 2070.1868  Tiletamine or Zolazepam or Both

Tiletamine or zolazepam or both, or any salt of either of them.  Some trade or other names for a tiletamine-zolazepam combination product:  Telazol.  Some trade or other names for tiletamine:  2-(ethylamino)-2-(2-thienyl)- cyclohexanone.  Some trade or other names for zolazepam:  4-(2-fluorophenyl)- 6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1870  Pentazocine and Aspirin Compound

Any material, compound, mixture or preparation containing not more than 12.5 milligrams of pentazocine or any of its salts, per 325 milligrams of aspirin.

Section 2070.1875  Pentazocine and Acetaminophine

Any material, compound, mixture or preparation containing not more than 25 milligrams of Pentazocine or any of its salts, per 650 milligrams of Acetaminophen.

Section 2070.1880  Pentazocine and Naloxone

Pentazocine and Naloxone

Any material, compound, mixture or preparation containing not more than 50 milligrams of pentazocine or any of its salts plus naloxone HCl USP 0.5 milligrams, per dosage unit.

(Source:  Added at 10 Ill. Reg. 19709, effective November 6, 1986)

Section 2070.1890  Nalorphine

Nalorphine

Section 2070.1900  Narcotic Drugs

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the narcotic drugs listed in Sections 2070.1905 to 2070.1940, or their salts calculated as the free anhydrous base or alkaloid.

Section 2070.1905  Codeine

Not more than 1.8 grams of codeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.

Section 2070.1910  Codeine

Not more than 1.8 grams of codeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts.

Section 2070.1915  Dihydrocodeinone

Not more than 300 milligrams of dihydrocodeinone, or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.

Section 2070.1920  Dihydrocodeinone

Not more than 300 milligrams of dihydrocodeinone, or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

Section 2070.1925  Dihydrocodeine

Not more than 1.8 grams of dihydrocodeine, or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

Section 2070.1930  Ethylmorphine

Not more than 300 milligrams of ethylmorphine or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

Section 2070.1935  Opium

Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

Section 2070.1940  Morphine

Not more than 50 milligrams of morphine, or any of its salts, per 100 milliliters or per 100 grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

Section 2070.1960  Anabolic Steroids

Anabolic steroids, except the following anabolic steroids listed in Sections 2070.1962 to 2070.1992 that are exempt.

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1962  Androgen L.A.

Androgen L.A.

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1964  Andro-Estro 90-4

Andro-Estro 90-4

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1966  depANDROGYN

depANDROGYN

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1968  DEPO-T.E.

DEPO-T.E.

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1970  depTESTROGEN

depTESTROGEN

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1972  Duomone

Duomone

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1974  DURATESTRIN

DURATESTRIN

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1976  DUO-SPAN II

DUO-SPAN II

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1978  Estratest

Estratest

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1980  Estratest H.S.

Estratest H.S.

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1982  PAN ESTRA TEST

PAN ESTRA TEST

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1984  Premarin with Methyltestosterone

Premarin with Methyltestosterone

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1986  TEST-ESTRO Cypionates

TEST-ESTRO Cypionates

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1988  Testosterone Cyp-50-Estradiol Cyp 2

Testrosterone Cyp-50-Estradiol Cyp 2

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1990  Testosterone Cypionate-Estradiol Cypionate Injection

Testosterone Cypionate-Estradiol Cypionate injection

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1992  Testosterone Enanthate-Estradiol Valerate Injection

Testosterone Enanthate-Estradiol Valerate injection

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.1995 Dronabinol (capsules)

Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelation capsule in a U.S. Food and Drug Administration-approved drug product.  Some other names:  (6aR-trans)-6a,7,8,10a_tetrahydro-6,6,9- trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-o1; (-)-delta-9(trans)- tetrahydrocannabinol.

(Source:  Added at 45 Ill. Reg. 13018, effective October 4, 2021)

Section 2070.2000  Excepted Compounds

The Department may except by rule any compound, mixture, or preparation containing any stimulant or depressant substance listed in Sections 2070.1610 and 2070.1700 from the application of all or any part of this Act if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.

Section 2070.2100  Schedule IV − Criteria

The Department finds that the substances enumerated in Schedule IV following meet the criteria established in Section 209 of the Act.

Section 2070.2105  Schedule IV − Enumeration

The controlled substances listed in these Sections 2070.2110 through 2070.2600 are included in Schedule IV.

Section 2070.2110  Narcotic Drugs

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs listed in Sections 2070.2115 and 2070.2120, or their salts calculated as the free anhydrous base or alkaloid.

Section 2070.2115  Difenoxin and Atropine Sulfate

Not more than 1 milligram of difenoxin (DEA Drug Code No. 9618) and not less than 25 micrograms of atropine sulfate per dosage unit.

Section 2070.2120  Dextropropoxyphine

Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane).

Section 2070.2200  Depressants

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.2210 to 2070.2325 having a potential for abuse associated with a depressant effect on the central nervous system.

Section 2070.2210  Alprazolam

Alprazolam

Section 2070.2215  Barbital

Barbital

Section 2070.2217  Bromazepam

Bromazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2218  Camazepam

Camazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2220  Chloral Betaine

Chloral betaine

Section 2070.2225  Chloral Hydrate

Chloral hydrate

Section 2070.2230  Chlordiazepoxide

Chlordiazepoxide

Section 2070.2232  Clobazam

Clobazam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2235  Clonazepam

Clonazepam

Section 2070.2240  Clorazepate

Clorazepate

Section 2070.2241  Clotiazepam

Clotiazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2242  Cloxazolam

Cloxazolam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2244  Delorazepam

Delorazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2245  Diazepam

Diazepam

Section 2070.2246  Eluxadoline

Eluxadoline 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1 H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid

(Source:  Added by peremptory rulemaking at 39 Ill. Reg. 16482, effective December 17, 2015)

Section 2070.2248  Estazolam

Estazolam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2250  Ethchlorvynol

Ethchlorvynol

Section 2070.2255  Ethinamate

Ethinamate

Section 2070.2256  Ethyl Loflazepate

Ethyl loflazepate

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2258  Fludiazepam

Fludiazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2259  Flunitrazepam

Flunitrazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2260  Flurazepam

Flurazepam

Section 2070.2265  Halazepam

Halazepam

Section 2070.2266  Haloxazolam

Haloxazolam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2268  Ketazolam

Ketazolam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2269  Loprazolam

Loprazolam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2270  Lorazepam

Lorazepam

Section 2070.2272  Lormetazepam

Lormetazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2275  Mebutamate

Mebutamate

Section 2070.2277  Medazepam

Medazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2280  Meprobamate

Meprobamate

Section 2070.2285  Methohexital

Methohexital

Section 2070.2290  Mephobarbital

Methylphenobarbital (Mephobarbital)

Section 2070.2291  Midazolam

Midazolam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2292  Nimetazepam

Nimetazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2293  Nitrazepam

Nitrazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2294  Nordiazepam

Nordiazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2295  Oxazepam

Oxazepam

Section 2070.2297  Oxazolam

Oxazolam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2300  Paraldehyde

Paraldehyde

Section 2070.2305  Petrichloral

Petrichloral

Section 2070.2310  Phenobarbital

Phenobarbital

Section 2070.2312  Pinazepam

Pinazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2315  Prazepam

Prazepam

Section 2070.2317  Quazepam

Quazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2320  Temazepan

Temazepan

Section 2070.2322  Tetrazepam

Tetrazepam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2325  Triazolam

Triazolam

(Source:  Added at 8 Ill. Reg. 16760, effective September 14, 1984)

Section 2070.2350  Zolpidam

Zolpidam

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2400  Fenfluramine

Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible: Fenfluramine

Section 2070.2500  Stimulants

Unless specifically excepted or unless listed in another schedule any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1605 to 2070.2580 having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

Section 2070.2503  Cathine

Cathine ((+)-norpseudoephedrine)

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2505  Diethylpropion

Diethylpropion

Section 2070.2515  Fencamfamin

Fencamfamin

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2520  Fenproporex

Fenproporex

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2540  Mazindol

Mazindol

(Source:  Renumbered from Section 2070.1635 at 6 Ill. Reg. 7200, effective June 7, 1982)

Section 2070.2545  Mefenorex

Mefenorex

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2565  Phentermine

Phentermine

Section 2070.2570  Pemoline

Pemoline (including organometallic complexes and chelates thereof).

Section 2070.2575  Pipradrol

Pipradrol

Section 2070.2580  SPA

SPA ((-)-1-dimethylamino-1, 2-diphenylethane).

Section 2070.2600  Excepted Compounds

The Department may except by rule any compound, mixture, or preparation containing any depressant substance listed in Section 2070.2110 from the application of all or any part of this Act if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system.

Section 2070.2650  Stimulants

Any material, compound, mixture, or preparation that contains any quantity of the following substance listed in Section 2070.2655 having a stimulant effect on the central nervous system, including its salts, enantiomers (optical isomers) and salts of enantiomers (optical isomers).

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2655  Ephedrine

Ephedrine as the only active medicinal ingredient or in combination with therapeutically insignificant quantities of another active medicinal ingredient.  Anything less than 200 milligrams of Guaifenesin shall be considered therapeutically insignificant.

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2700  Schedule V − Criteria

The Department finds that the substances enumerated in Schedule V following meet the criteria established in Section 211 of the Act.

Section 2070.2705  Schedule V − Enumeration

The controlled substances listed in these Sections 2070.2710 to 2070.2800 are included in Schedule V.

Section 2070.2710  Narcotic Drugs

Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs listed in Sections 2070.2715 to 2070.2740, or their salts calculated as the free anhydrous base or alkaloid, which also contains one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone.

Section 2070.2712  Buprenorphine

Buprenorphine

(Source:  Added at 9 Ill. Reg. 10649, effective July 2, 1985)

Section 2070.2715  Codeine

Not more than 200 milligrams of codeine, or any of its salts, per 100 milliliters or per 100 grams.

Section 2070.2720  Dihydrocodeine

Not more than 100 milligrams of dihydrocodeine; or any of its salts, per 100 milliliters or per 100 grams.

Section 2070.2723  -Methylfentanyl

3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)

(Source:  Section 2070.272 renumbered from Section 2070.247 and amended at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.2725  Ethylmorphine

Not more than 100 milligrams of ethylmorphine; or any of its salts, per 100 milliliters or per 100 grams.

Section 2070.2730  Diphenoxylate

Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.

Section 2070.2735  Opium

Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.

Section 2070.2740  Difenoxin

Not more than 0.5 milligram of difenoxin (DEA Drug Code No. 9618) and not less than 25 micrograms of atropine sulfate per dosage unit.

Section 2070.2750  Pyrovalerone

Pyrovalerone

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.2800  Other Substances

Any compound, mixture, or preparation which contains any quantity of any controlled substance when such compound, mixture, or preparation is not otherwise controlled in Schedules I, II, III, or IV.